FDA Approves Imfinzi and Enfortumab Vedotin Regimen for Bladder Cancer
The U.S. Food and Drug Administration approved a new drug combination on November 13, 2026, for adults with muscle-in...
Dr. Sameena Khan is a board-certified physician with over fifteen years of clinical practice dedicated to preventive healthcare and chronic disease management. At drsameenakhan.com, she translates complex clinical research into clear, evidence-based health guidance for patients. Dr. Khan rigorously reviews medical literature to ensure all educational resources adhere to current clinical practice guidelines.